Justin Hawley, MBA, RT(T)’s Post

In this interactive roundtable—the first in a three-part series—our team discusses key opportunities, scientific innovations and insights driving acceleration of preclinical gene therapy programs to IND/CTA and beyond. Watch the roundtable here #GeneTherapy #PrecisionMedicine

Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond, Oct. 24, 2023 | Labcorp

Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond, Oct. 24, 2023 | Labcorp

learn-more.com

To view or add a comment, sign in

Explore topics